The contents of these web pages are prepared and directed to both
the continuing education and updating the activities of veterinarians.

First four-month 2012

In the meeting of March 2nd 2012 in Rome the detailed activity of 2012 was organized.
In the occasion, the CLWG confirmed that are still lacking evidence of the efficacy of domperidone in canine leishmaniosis due to a reduced number of papers to support the action of this drug. In addition, the CLWG stated the same questioning for the action of the vaccine that will be launched in the Italian market from Virbac (CaniLeish®). The CLWG regret that the scientific documentation supporting the vaccine introduction was available only after the product was already disclosed to the common media directed to the consumers besides dog’s owner.

A price of 1,000 euros for the best oral communication presented during the Canine Leishmaniosis session inside the annual congress of SCIVAC in Rimini from next 8-10 June will be awarded.

The guidelines of CLWG about prognosis and monitoring of canine leishmaniosis were discussed in detail. These guidelines will be published soon in the Veterinaria journal. A similar paper will be prepared also for the prestigious Veterinary Journal.

The CLWG also approved definitively the program of Canine Leishmaniosis session that will be held inside the annual congress SCIVAC of RIMINI next Saturday June 9th. The program includes the presentation of two main lectures and three scientific communications as below reported:

  • “Course, prognosis and monitoring of dogs affected by leishmaniosis” presented by Fondati A and Roura X.
  • “Pathogenesis and management of proteinuria in the dog affected by leishmaniosis” presented by Zatelli A. and Zini E.
  • “Clinical efficacy of a Leisguard®-based program strategically established for the prevention of canine leishmaniosis in endemic areas with low prevalence”
  • “Efficacy of combined therapy with meglumine antimoniate and domperidone for treatment of canine leishmaniosis”
  • “Test of thyroid function in dogs affected by leishmaniosis: preliminary study”

CLWG News

The Executive Board of CLWG has been renewed
On the occasion for the autumnal meeting of CLWG that has been held in Rome on November 10th, 2023, a general and extraordinary assembly to renew the Executive Board has been organized. Indeed, the regular expiry of the Executive Board was originally set at the end of March 2024. Due to administrative reasons the deadline has been anticipated of few months.
prof. Domenico Otranto

In the autumnal meeting of CLWG that has been held in Rome the last November 10th, 2023, the participation as effective member of CLWG of Prof. Domenico Otranto has been approved by the general assembly. 

Prof. Otranto is a full professor of Parassitological Disease at the University of Bari, Department of Veterinary Medicine and diplomate of European Board of Veterinary Specialist in Parassitology. 

CLWG meeting of Novarello, September 18th, 2022 Canine leishmaniosis: old and new evidence. Let’s talk together

After almost two years of scientific and continuing education del CLWG using remote connections, a scientific meeting of continuing education on site has been organized at Granozzo di Monticello, Novara whose title is “Canine leishmaniosis: old and new evidence. Let’s talk together”. To attend this meeting is necessary the registration. The planning of the meeting is organized with five presentations:

In order to streamline the study above different features of canine leishmaniasis the following three subgroups have been established:

Management and implementation of studies and protocols on canine leishmaniasis: Dr. Michele Maroli (coordinator), Dr. Nunzio D’Anna, Dr. Luigi Gradoni, Dr. Alessandra Fondati, Prof. George Lubas, Prof. Saverio Paltrinieri, Dr. Xavier Roura, Prof. Andrea Zatelli, Dr. Eric Zini

Nephrology and Leishmaniasis: Prof. Andrea Zatelli, Dr. Xavier Roura, Prof. Oscar Cortadellas, Dr. Silvia Benali.

CLWG management and promotion: Prof. George Lubas (coordinator), Dr. Paola Bianchi.